Results after intensified therapy for advanced carcinoma of the hypopharynx

Ear, Nose and Throat Journal

Volumn 87, Issue 8, 2008, Pages

  Windfuhr, Jochen P ^a   Andrae, Mathias ^a   Chen, Yue Shih ^b   Makoski, Hans B ^c   Schröder, Michael ^d   Sesterhenn, Klaus ^a  

^a Malteser Krankenhaus St Anna   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c Wedau Kliniken   (Germany)

^d ST JOHANNES HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EAR NOSE THROAT SURGERY; FEMALE; HUMAN; HYPOPHARYNX CARCINOMA; LARYNGECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PROGNOSIS; QUALITY OF LIFE;

EID: 50049116962     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Adelstein DJ, Hines JD, Sharan VM, et al. Combination chemotherapy prior to definitive local therapy in squamous cell carcinoma of the head and neck. Oncology 1985; 42 (2): 80-5.
2. Adelstein DJ, Sharan VM, Earle AS, et al.Simultaneous radiotherapy and chemotherapy with 5-fluorouracil and cisplatin for locally confined squamous cell head and neck cancer. NCI Monogr 1988;(6): 347-51.
3. Adelstein DJ, Sharan VM, Earle AS, et al. Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer. Cancer 1990; 65 (8): 1685-91.
4. Adelstein DJ, Sharan VM, Earle AS, et al. Long-term results after chemoradiotherapy for locally confined squamous-cell head and neck cancer. Am J Clin Oncol 1990; 13 (5): 440-7.
5. Mohr C, Bohndorf W, Carstens J, et al. Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up). Int J Oral Maxillofac Surg 1994; 23 (3): 140-8.
6. Hoffman HT, Karnell LH, Shah JP, et al. Hypopharyngeal cancer patient care evaluation. Laryngoscope 1997; 107 (8): 1005-17.
7. Mendenhall WM, Parsons JT, Stringer SP, et al. Radiotherapy alone or combined with neck dissection for T1-T2 carcinoma of the pyriform sinus: An alternative to conservation surgery. Int J Radiat Oncol Biol Phys 1993; 27 (5): 1017-27.
8. Godballe C, Jørgensen K, Hansen O, Bastholt L. Hypopharyngeal cancer: Results of treatment based on radiation therapy and salvage surgery. Laryngoscope 2002; 112 (5): 834-8.
9. Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992; 23 (2): 457-67.
10. Hansen O, Overgaard J, Hansen HS, et al. Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: Dependency on tumor differentiation. Radiother Oncol 1997; 43 (1): 47-51.
11. Steiner W, Ambrosch P, Hess CF, Kron M. Organ preservation by transoral laser microsurgery in piriform sinus carcinoma. Otolaryngol Head Neck Surg 2001; 124 (1): 58-67.
12. Rudert HH, Höft S. Transoral carbon-dioxide laser resection of hypopharyngeal carcinoma. Eur Arch Otorhinolaryngol 2003; 260 (4): 198-206.
13. Ambrosch P, Kron M, Pradier O, Steiner W. Efficacy of selective neck dissection: A review of 503 cases of elective and therapeutic treatment of the neck in squamous cell carcinoma of the upper aerodigestive tract. Otolaryngol Head Neck Surg 2001; 124 (2): 180-7.
14. Ho CM, Lam KH, Wei WI, et al. Squamous cell carcinoma of the hypopharynx - analysis of treatment results. Head Neck 1993; 15 (5): 405-12.
15. Johnson JT, Bacon GW, Myers EN, et al. Medial vs lateral wall pyriform sinus carcinoma: Implications for management of regional lymphatics. Head Neck 1994; 16 (5): 401-5.
16. Kraus DH, Zelefsky MJ, Brock HA, et al. Combined surgery and radiation therapy for squamous cell carcinoma of the hypopharynx. Otolaryngol Head Neck Surg 1997; 116 (6 Pt 1): 637-41.
17. Vandenbrouck C, Eschwege F, De la Rochefordiere A, et al. Squamous cell carcinoma of the pyriform sinus: Retrospective study of 351 cases treated at the Institut Gustave-Roussy. Head Neck Surg 1987; 10 (1): 4-13.
18. Raghavan U, Quraishi S, Bradley PJ. Multiple primary tumors in patients diagnosed with hypopharyngeal cancer. Otolaryngol Head Neck Surg 2003; 128 (3): 419-25.
19. Spector JG, Sessions DG, Haughey BH, et al. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope 2001; 111 (6): 1079-87.
20. León X, Quer M, Diez S, et al. Second neoplasm in patients with head and neck cancer. Head Neck 1999; 21 (3): 204-10.
21. Ogura JH, Marks JE, Freeman RB. Results of conservation surgery for cancers of the supraglottis and pyriform sinus. Laryngoscope 1980; 90 (4): 591-600.
22. Laccourreye H, Lacau St. Guily J, Brasnu D, et al. Supracricoid hemilaryngopharyngectomy. Analysis of 240 cases. Ann Otol Rhinol Laryngol 1987; 96 (2 Pt 1): 217-21.
23. Spector JG, Sessions DG, Emami B, et al. Squamous cell carcinoma of the pyriform sinus: A nonrandomized comparison of therapeutic modalities and long-term results. Laryngoscope 1995; 105 (4 Pt 1): 397-406.
24. Allal AS. Cancer of the pyriform sinus: Trends towards conservative treatment. Bull Cancer 1997; 84 (7): 757-62.
25. Lefebvre JL, Chevalier D, Luboinski B, et al. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996; 88 (13): 890-9.
26. Lefebvre JL. Larynx preservation: The discussion is not closed. Otolaryngol Head Neck Surg 1998; 118 (3 Pt 1): 389-93.
27. Wolf GT, Forastiere A, Ang K, et al. Workshop report: Organ preservation strategies in advanced head and neck cancer-current status and future directions. Head Neck 1999; 21 (8): 689-93.
28. Wirth LJ, Posner MR. Recent advances in combined modality therapy for locally advanced head and neck cancer. Curr Cancer Drug Targets 2007; 7 (7): 674-80.
29. Pignon JP, Bourhis J, Domenge C, Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000; 355 (9208): 949-55.
30. Harari PM. Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice? J Clin Oncol 1997; 15 (5): 2050-5.
31. Beauvillain C, Mahé M, Bourdin S, et al. Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinomas. Laryngoscope 1997; 107 (5): 648-53.
32. Hypopharyngeal cancer treatment (PDQ®). National Cancer Institute Web site. http://www.cancer.gov/cancertopics/pdq/treatment/hypopharyngeal/ HealthProfessional/page2. Updated May 8, 2008. Accessed July 8, 2008.